Jacobio Pharmaceuticals Group Co., Ltd. (HK:1167) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Jacobio Pharmaceuticals Group Co., Ltd. will showcase clinical data for their BET inhibitor, JAB-8263, at the upcoming 66th American Society of Hematology Annual Meeting in December 2024. The company, which is dedicated to creating innovative health solutions across six major signaling pathways, cautions there is no guarantee of JAB-8263’s successful development or marketability.
For further insights into HK:1167 stock, check out TipRanks’ Stock Analysis page.